Menstrual Cycle Phase Influences Cognitive Performance in Women and Modulates Sex Differences: A Combined Longitudinal and Cross-Sectional Study PDF Free Download

1 / 22
3 views22 pages

Menstrual Cycle Phase Influences Cognitive Performance in Women and Modulates Sex Differences: A Combined Longitudinal and Cross-Sectional Study PDF Free Download

Menstrual Cycle Phase Influences Cognitive Performance in Women and Modulates Sex Differences: A Combined Longitudinal and Cross-Sectional Study PDF free Download. Think more deeply and widely.

Academic Editor: Paul D. Terry
Received: 2 July 2025
Revised: 1 August 2025
Accepted: 11 August 2025
Published: 15 August 2025
Citation: Sawicka, A.K.; Michalak,
K.M.; Naparło, B.; Bermudo-Gallaguet,
A.; Mataró, M.; Winklewski, P.J.;
Marcinkowska, A.B. Menstrual Cycle
Phase Influences Cognitive
Performance in Women and
Modulates Sex Differences:
A Combined Longitudinal and
Cross-Sectional Study. Biology 2025,14,
1060. https://doi.org/10.3390/
biology14081060
Copyright: © 2025 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license
(https://creativecommons.org/
licenses/by/4.0/).
Article
Menstrual Cycle Phase Influences Cognitive Performance in
Women and Modulates Sex Differences: A Combined
Longitudinal and Cross-Sectional Study
Angelika K. Sawicka 1,* , Katarzyna M. Michalak 1,* , Barbara Naparło 1, AdriàBermudo-Gallaguet 2,3,4 ,
Maria Mataró 2,3,4, Pawel J. Winklewski 5,6 and Anna B. Marcinkowska 1,7
1Applied Cognitive Neuroscience Lab, Department of Neurophysiology, Neuropsychology and
Neuroinformatics, Medical University of Gdansk, 80-211 Gdansk, Poland; rabarbara@gumed.edu.pl (B.N.);
anna.marcinkowska@gumed.edu.pl (A.B.M.)
2Departament de Psicologia Clínica i Psicobiologia, Facultat de Psicologia, Universitat de Barcelona (UB),
Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain; abermudo@ub.edu (A.B.-G.);
mmataro@ub.edu (M.M.)
3
Institut de Neurociències, Universitat de Barcelona, Passeig de la Vall d’Hebron, 171, 08035 Barcelona, Spain
4Institut de Recerca Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain
5Department of Neurophysiology, Neuropsychology and Neuroinformatics, Medical University of Gdansk,
80-211 Gdansk, Poland; pawel.winklewski@gumed.edu.pl
6Institute of Health Sciences, Pomeranian University in Slupsk, 76-200 Slupsk, Poland
72nd Department of Radiology, Medical University of Gdansk, 80-211 Gdansk, Poland
*Correspondence: angelika.sawicka@gumed.edu.pl (A.K.S.); k.michalak@gumed.edu.pl (K.M.M.)
Simple Summary
Hormonal fluctuations during the menstrual cycle can impact a woman’s performance on
tasks that require memory, attention, and cognitive processing speed. These changes could
also help explain cognitive differences between women and men. In this study, we tested
71 young adults on a series of cognitive tasks. Women were assessed twice: during the
menstrual phase (low hormone levels) and the pre-ovulatory phase (when oestradiol is
high). Men were tested once. We found that women performed better on memory and
attention tasks just before ovulation. Differences in processing speed between men and
women were observed only during women’s menstrual phase. These differences disap-
peared when oestradiol levels were higher (before ovulation). In men, better performance
was also linked to higher oestradiol and progesterone. Our results suggest that oestradiol
plays an important role in cognitive changes during the menstrual cycle. Recognising hor-
monal variation, especially in oestradiol, may be essential when studying sex differences
in cognition.
Abstract
Sex hormones’ and menstrual cycle’s effects on cognitive performance remain unclear.
This study examined cognitive differences between women across menstrual cycle phases,
sex differences between women and men, and hormone–cognition associations. In total,
71 healthy young adults, aged 20–36 (42 women, 29 men), completed standardised cognitive
tests measuring attention, processing speed, working memory, and visuospatial abilities.
Women were tested twice: during menstrual (low-oestradiol) and pre-ovulatory (high-
oestradiol) phases; men once. Hormone levels (oestradiol, progesterone, testosterone)
were measured in blood samples via electrochemiluminescence immunoassay (ECLIA).
Two analytical strategies were used: (1) within-subject analysis comparing women between
phases, and (2) between-group comparison across three groups—women in menstrual
phase, pre-ovulatory phase, and men. Women performed better during pre-ovulatory
Biology 2025,14, 1060 https://doi.org/10.3390/biology14081060
Biology 2025,14, 1060 2 of 22
versus menstrual phase in working memory (Digit span forward: p= 0.04; Digit span
backwards max: p= 0.02) and attention switching (Trail Making Test B: p= 0.01). Sex
differences in processing speed were observed only during the menstrual phase (Trail
Making Test A: p= 0.03; Stroop B: p= 0.04), but not in the pre-ovulatory phase. Positive
correlations between oestradiol/progesterone and cognitive performance were found in
men, while complex bidirectional relationships emerged in women during the menstrual
phase only. Testosterone showed no significant correlations. These findings highlight
hormonal status effects on cognitive sex differences.
Keywords: menstrual cycle; gonadal steroid hormones; memory short-term; attention; sex
characteristics; oestradiol; follicular phase
1. Introduction
The menstrual cycle, characterised by dramatic fluctuations in sex hormone levels,
provides a natural model for studying hormonal influence on cognition. The menstrual
cycle begins with the early follicular phase, characterised by low progesterone and oe-
strogen levels. Oestrogen levels rise rapidly in the late follicular phase, showing a nearly
eight-fold increase and a peak one day before ovulation. The luteal phase sees a steady
rise in progesterone levels that peaks in the mid-luteal phase with an 80-fold increase,
accompanied by a second oestrogen peak. Both hormone levels decline during the late
luteal phase, reaching baseline shortly before the onset of menstruation [1,2].
Research shows that steroid hormones, their fluctuations, and their receptors play a
significant role in various brain functions, including regulating socio-sexual behaviour,
neurogenesis, cognitive function, mood, and emotion [
3
,
4
]. oestrogen receptors (ERs)
and progesterone receptors (PRs) are found throughout the brain in regions involved
in cognitive and emotional regulation [
3
5
]. Through these receptors, sex hormones
influence cognitive function via multiple mechanisms, including the modulation of
neurotransmitter systems, the regulation of synaptic plasticity, and effects on neural
connectivity [68].
In young women, evidence suggests that hormonal fluctuations can induce reversible
structural changes in the brain. Research has demonstrated that grey matter volume in
young women exhibits relative increases in the right anterior hippocampus and relative
decreases in the right dorsal basal ganglia during the postmenstrual phase [
9
]. It has been
proven that oestrogen improves performance in prefrontal cortex-dependent learning
in animal and human studies [
10
12
]. Related changes were seen in studies of healthy
women showing differential Stroop task performance between phases characterised by
low versus high concentrations of oestradiol and progesterone during the menstrual
cycle [
13
]. These results suggest that sex-related hormone modulation selectively affects
cognitive function depending on the type of task and that low levels of oestradiol secretion
appear to contribute to a reduction in the level of attention related to the aforementioned
prefrontal cortex. According to research, higher oestrogen levels have a protective effect
on cognitive functioning [
5
] and positively correlate with processing speed and sustained
attention [
14
]. Furthermore, oestrogen is involved in memory processes and can also
affect different types of memory, such as episodic memory, working memory [
15
], and
long-term memory [
16
]. Additionally, oestradiol may modulate visuospatial functions,
including visuospatial orientation [
17
] and visuospatial memory [
18
]. Regarding pro-
gesterone, an fMRI study proved that this hormone modulates limbic and somatomotor
networks, which can improve cognitive function in naturally cycling young women [
19
].
Biology 2025,14, 1060 3 of 22
Both oestrogen and progesterone treatments have shown potential cognitive benefits
in women, with progesterone showing better effects on verbal working memory [
20
].
Testosterone, on the other hand, activates a distributed cortical network, the ventral pro-
cessing stream, during spatial cognition tasks, and the addition of testosterone improves
spatial cognition in men [
21
]. According to research, testosterone also protects the brain
against oxidative stress, serum deprivation-induced apoptosis, and soluble amyloid-
β
(A
β
) toxicity [
22
]. Recent research has suggested that testosterone’s effects on cognition
may be particularly important in women, especially in those carrying genetic risk factors
for cognitive decline [
23
]. This hormone can be converted to oestradiol in the brain
through aromatisation, thereby potentially affecting cognition through both androgen
and oestrogen-dependent mechanisms [
24
]. Studies have suggested the involvement
of testosterone in spatial abilities and working memory, though its effects may differ
between men and women [24,25].
However, despite numerous studies suggesting that cognitive functions in women vary
depending on the phase of the menstrual cycle and hormone levels, the scientific literature
remains inconsistent, and several studies have not found significant changes [
26
28
]. These
contradictory findings may stem from methodological differences, including reliance on
estimated cycle phases rather than quantitative hormonal measurements, variations in
cognitive testing batteries employed, and differences in participant characteristics and
sample sizes.
In summary, steroid hormones, especially oestradiol, may influence cognitive function
in areas critical for daily functioning and academic achievement, making them particularly
relevant for the study of hormone-dependent changes in cognitive function in young
adult women. However, the exact nature of these relationships within the menstrual cycle
remains unclear, especially regarding their potential impact on sex differences in cognitive
functioning between women and men.
Building on the existing literature, we aimed to investigate three key research ques-
tions. First, we examined whether women’s cognitive functioning changes across the
menstrual cycle phases, focusing on attention, processing speed, short-term and work-
ing memory, and visuospatial abilities. We hypothesised that performance would be
enhanced during the pre-ovulatory phase (high oestradiol) compared to the menstrual
phase (low oestradiol and progesterone), reflecting primarily the facilitating effects of
elevated oestradiol levels, particularly in tasks measuring working memory [
10
,
12
], pro-
cessing speed [
14
], and attention [
19
]. Second, we investigated sex differences in cognitive
functioning between young, healthy women and men, comparing men with women in
both menstrual cycle phases to determine whether these differences are modulated by
hormonal status. Here, we expected to find sex differences in information processing
speed and visuospatial abilities, with these differences being dependent on women’s
menstrual cycle phase [
17
,
21
]. Third, we explored associations between sex hormone
levels (oestradiol, progesterone, and testosterone) and cognitive performance in both men
and women, comparing the menstrual phase (lowest oestradiol) with the pre-ovulatory
phase (highest oestradiol). For this aim, we hypothesised that higher oestradiol levels
would be associated with better working memory and attention performance [
10
,
12
],
progesterone levels would show an association with cognitive performance, in line with
previous research, through underlying neural mechanisms (the limbic and somatomotor
networks) [
19
], and testosterone levels would demonstrate positive relationships with
spatial abilities and working memory [24,25].
Biology 2025,14, 1060 4 of 22
In this study, we specifically chose to compare the menstrual phase (days 2–5 after
menstruation onset) and the pre-ovulatory phase (up to 2 days before expected ovulation)
for several methodological and theoretical reasons. These two phases represent the most
distinct hormonal profiles within the menstrual cycle, with the menstrual phase charac-
terised by minimal levels of both oestradiol and progesterone, while the pre-ovulatory
phase features a pronounced oestradiol peak with still relatively low progesterone. This
hormonal contrast provides an optimal window to examine oestradiol’s specific effects on
cognition with minimal confounding influence from progesterone.
To address these research questions, the study employed two analytical approaches:
(1) a longitudinal analysis including only women, comparing their cognitive performance
across the menstrual and pre-ovulatory phases, and (2) a cross-sectional analysis comparing
men and women at each phase. By combining these two approaches, we provided new
insights into sex differences and hormonal fluctuations within the same examination group.
By measuring hormone levels, we could exclude nonspecific patients with irregular cycles
or without hormone peaks fitting the normal range for the cycle phase. For methodological
consistency in the latter approach, only data from women’s first evaluation sessions were
used compared with men.
2. Materials and Methods
2.1. Ethics Statement
All participants were informed about the procedures, risks, and expected outcomes
before starting the assessment procedure and gave their written informed consent for
participation. The study was conducted under the Declaration of Helsinki. The study
protocol was approved by the Independent Bioethics Commission for Research at the
Medical University of Gdansk (NKBBN/398/2021 and NKBBN/398-14/2023).
2.2. Participants
Recruitment for the study was conducted continuously between December 2022
and November 2023. The participants were recruited through the universities’ methods
of communication, such as mailing lists and advertisements on social media. The qual-
ifications for the study were assessed using an online questionnaire and consultation.
A diverse group of 115 people applied for the study, of whom 104 were accepted for the
study procedure. Inclusion criteria for all participants were as follows: an age range
of
18–36 years
and being a native Polish speaker. For women, an additional inclusion
criterion was a regular menstrual cycle length defined as 24 to 38 days (as defined by the
International Federation of Gynaecology and Obstetrics (FIGO) in 2018), with a variation
in duration between cycles of no more than 8 days [
29
]. The non-inclusion criteria were
as follows: any neurological or mental disorder, current use of psychiatric medications,
chronic diseases (such as diabetes), irregular menstruation in women, endometriosis or
polycystic ovary syndrome, current or recent (within the past six months) use of hormonal
contraceptives, current or past hormone therapy, current pregnancy, and postpartum
period or breastfeeding within one year prior to the study. In addition, women who
showed inconsistency between their declared cycle phase and measured hormone levels
were excluded from the statistical analysis. Ultimately, 71 young, healthy adults were
included in the statistical analyses—42 women (mean
age = 23.64 ±3.53
) and 29 men
(mean age = 24.1 ±3.46). All participants had comparable education levels (mean years
of education = 16.02
±
2.48) and body mass index (BMI;
mean = 23.09 ±3.72
), ensuring a
high degree of group homogeneity (Figure 1).
Biology 2025,14, 1060 5 of 22
Figure 1. Trial flow diagram. Note: The diagram illustrates the recruitment, screening, and selection
process for all participants in the study. The final sample, consisting of 71 participants, comprised
42 women and 29 men.
2.3. Study Design
To address our research questions, two main analytical approaches were used
(Figure 2).
(1) Longitudinal analysis (within women): To compare women’s cognitive functioning
between the menstrual and pre-ovulatory phases, the Wilcoxon signed-rank test with a
calculated effect size was used for dependent groups.
(2) Cross-sectional analysis (between men and women): To compare cognitive per-
formance between men and women, participants were divided into three independent
groups: men (M; n = 29), women in the menstrual phase (W1; n = 26), and women in the
pre-ovulatory phase (W2; n = 16). The groups of women (W1 and W2) were established
based on the phase in which they underwent their first neuropsychological assessment to
ensure methodological homogeneity and avoid practice effects when comparing with men,
who were tested only once. The Kruskal–Wallis test, followed by post hoc Mann–Whitney
U tests, was used to evaluate differences between these three groups.
Biology 2025,14, 1060 6 of 22
Figure 2. Study design overview: Two-stage analytical approach. Note: Stage 1—Longitudinal
Analysis (within-subject comparison): Women (n = 42) were assessed at two time points within the
same menstrual cycle (during the menstrual phase (low oestradiol) and pre-ovulatory phase (high
oestradiol)), allowing for within-subject comparisons of cognitive performance across hormonal
states. Stage 2—Cross-sectional Analysis (between subject comparison): For sex difference analyses,
participants were reorganised into three independent groups based on the timing of the first cognitive
assessment: Men (M; n = 29) who underwent a single assessment, Women (W1; n = 16) whose first
assessment occurred during the menstrual phase, and Women (W2; n = 26) whose first assessment
occurred during the pre-ovulatory phase. This approach enabled between-group comparisons
while controlling for practice effects by using only first-session data from women when comparing
with men.
2.4. Assessment Timing
To precisely determine assessment periods coinciding with specific hormonal states,
we implemented a structured menstrual cycle tracking protocol. Female participants
completed a reproductive history questionnaire documenting cycle regularity, average
cycle length (calculated from the preceding three menstrual cycles), and the onset date of
their most recent menstruation. All women included in the final analysis exhibited regular
menstrual cycles (ranging between 24 and 38 days) [29].
Assessments were scheduled during two distinct cycle phases characterised by maxi-
mally differentiated oestradiol profiles: the menstrual phase (days 2–5 post-menstruation
onset), corresponding to minimal oestradiol and progesterone concentrations; and the
pre-ovulatory phase (0–2 days pre-ovulation), characterised by elevated oestradiol with
still relatively low progesterone levels [
30
]. Expected ovulation dates were calculated using
the reverse counting method (subtracting 14 days from the anticipated next menstruation)
and verified through confirmation of subsequent menstrual onset.
To control for potential practice effects while ensuring within-subject comparisons,
we employed a randomised crossover design in which all participants completed two
assessments—one during the menstrual phase and one during the pre-ovulatory phase.
Participants were randomly assigned to begin the study in either cycle phase, with their
second assessment scheduled in the alternate phase. This approach enabled us to follow
each woman across both hormonal conditions while controlling for potential order effects.
Following participant attrition and exclusion of cases with hormonal profiles inconsistent
Biology 2025,14, 1060 7 of 22
with expected phase values, the final analytical sample included 42 women (26 who began
in the menstrual phase and 16 who began in the pre-ovulatory phase). This design supports
robust within-subject comparisons while mitigating confounding practice effects.
2.5. Hormone Measurements
Before every cognitive examination, blood samples were collected from the partici-
pants to determine their hormone levels of progesterone, oestradiol, and testosterone. For
female participants, blood samples and cognitive tests were conducted twice, timed to
capture hormonal fluctuations across the menstrual cycle (once during the menstrual phase
and once during the pre-ovulatory phase). For male participants, blood sampling and
cognitive testing were performed once.
Blood tests were performed in the fasting state and collected in the morning, specifi-
cally between 7:00 and 10:00 a.m. The samples were collected and analysed by a certified
commercial laboratory using the electrochemiluminescence immunoassay (ECLIA) method
and Cobas Pro device.
The analytical performance characteristics for the assays were as follows: for oestradiol,
the limit of detection (LoD) was 18.4 pmol/L (5 pg/mL), the limit of quantification (LoQ)
was 91.8 pmol/L (25 pg/mL), intra-assay CV ranged from 1.2 to 5.4%, and inter-assay
CV ranged from 1.9 to 7.1%. For progesterone, the LoD was 0.159 nmol/L (0.05 ng/mL),
the LoQ was 0.636 nmol/L (0.2 ng/mL), intra-assay CV ranged from 1.3 to 3.2%, and
inter-assay CV ranged from 3.7 to 5.5%. For testosterone, the LoD was 0.087 nmol/L
(
0.025 ng/mL
), the LoQ was 0.416 nmol/L (0.120 ng/mL), intra-assay CV ranged from 1.1
to 3.0%, and inter-assay CV ranged from 2.3 to 5.1%. Precision was determined according
to CLSI (Clinical and Laboratory Standards Institute) protocol EP05-A3.
2.6. Cognitive Tests
Cognitive testing was conducted between 8:00 a.m. and 12:00 p.m. to ensure con-
sistency in timing and to control for potential circadian influences. During the neuropsy-
chological assessment, the participants completed six tests in a fixed order, as described
below. The total duration of the cognitive assessment was 45–60 min, depending on each
individual’s performance speed. Short breaks (2–3 min) were provided between the tests
when requested by the participants to minimise fatigue effects.
The Stroop test from the Delis–Kaplan Executive Function System (D-KEFS) bat-
tery [
31
] measures rapid processing, attentional selectivity, inhibitory processing, and
cognitive flexibility. It is a neuropsychological test widely used to assess the ability to
inhibit cognitive interference, which occurs when the processing of one stimulus feature
prevents the simultaneous processing of a second stimulus feature. This test contained
four conditions, each preceded by a short trial, and the time taken to complete each was
measured. The first task (A) was to say the colour of the squares (blue, red, and green), the
second (B) was to read words written in black ink as quickly as possible, the next (C) was
to say the colour of the ink in which the words were written (written colour names were
incongruent with the ink colour), and the final task (D) was to read a word written in an
ink colour incongruent with the name of the colour if written without a frame, or to say the
name of the colour according to the word that was written if the word was in a frame. All
the tasks were presented on white sheets of A4 paper lying horizontally. Word reading and
colour naming are measures of processing speed, while colour–word inhibition measures
executive functions [
32
]. In this test, we measured the time taken to complete each task and
the interference between each subtest.
Digit span forward and backwards repetition from the Wechsler Adult Intelligence
Scale [
33
] measures auditory short-term and working memory. The participants repeated
Biology 2025,14, 1060 8 of 22
an increasing number of random digits forward and then backwards in the order given
by the researcher. Each correctly repeated series was followed by another series plus an
additional digit. If the participant failed the first attempt, the subject was given a second
chance with a different set of numbers of the same length. If the subject failed the second
attempt, the test was terminated. In this test, we measured the number of points the subject
scored and the number of items correctly recalled in the longest sequence.
The trail making test (TMT) parts A and B [
34
] measure visual processing speed,
visual perceptual ability, working memory, task-switching ability, and executive control.
In part A, the participants had to match the following numbers on an A4 sheet of paper;
in part B, the numbers and letters alternated in alphabetical order. Before the actual test,
the participants completed a trial task. The time taken to complete the task was measured.
Another indicator of working memory performance was the ratio of the time taken to
complete part A to part B.
The Corsi block-tapping test [
35
] measures spatial short-term and working memory.
The test requires the maintenance of a visuospatial pattern and sequence of movements [
36
].
Corsi’s original apparatus consisted of a series of nine blocks arranged irregularly on a
board. The blocks were tapped by the experimenter in random sequences of increasing
length. There were two subtests: the forward and the backwards subtest. Immediately after
each tapped sequence, the participant attempted to reproduce it, progressing until they
failed to correctly reproduce two sequences of the same length [
37
]. As the test progressed,
the number of blocks increased. The score was assessed by the maximum number the
participant could reproduce correctly in the forward and backwards directions. The total
score forward (TSF) and total score backwards (TSB) indices gave the number of examples
performed correctly multiplied by the length of the sequence reproduced correctly.
The visual pattern test (VPT) [
38
] measures short-term non-verbal memory and mem-
ory for item sequences. There were two parallel sets of patterns, set A and set B, which
formed two parallel forms of the test, version A and version B, respectively. The grids
ranged in size from the smallest, a 2
×
2 matrix (with two filled cells), to the largest, a
5×6 matrix
(with 15 filled cells), with the complexity increasing progressively by adding
two additional cells to the previous grid. Therefore (assuming the simplest pattern can be
reproduced), the subject received a score ranging from 2 to 15 [
39
]. During the test, the
participants were shown patterns of black squares for three seconds and asked to reproduce
them from memory. The test was stopped when the participant incorrectly reproduced
three boards with the same number of cells. The result of the test was the maximum number
of elements that the participant was able to recall and the average number of the last three
examples that the participant got right.
The visual perceptual skills–subtests memory and sequence [
40
] measure short-term
visual recognition. Due to the young, healthy group of participants, the first six items in
each subtest were omitted—the items were too easy to recognise and did not differentiate.
The next 10 items were shown for three seconds, and the last six for 5 s. After viewing
each figure or sequence of elements, the participant was expected to identify and select the
correct one from other similar options. A maximum of 18 points could be scored. During the
test, the participant did not receive any feedback on whether they were speaking correctly.
2.7. Statistical Analysis
Statistical analyses were performed using the Statistical Package for Social Sciences
(SPSS) version 29 (IBM Corp., Armonk, NY, USA) and GraphPad Prism 8 (GraphPad
Software, San Diego, CA, USA).First, Shapiro–Wilk’s test was used to check for the normal
distribution of the variables. As the cognitive results and hormonal concentrations were
not normally distributed, non-parametric tests were performed.
Biology 2025,14, 1060 9 of 22
For the longitudinal part of the study, women’s cognitive performance in the
two phases of the menstrual cycle was compared using the Wilcoxon signed-rank test
with a calculated effect size. For the cross-sectional part of the study, women’s cognitive
performance in the two phases of the menstrual cycle was compared to men’s using the
Kruskal–Wallis test with a post hoc Mann–Whitney U test.
Correlations between the changes in hormone levels and cognitive performance were
calculated using partial correlation tests adjusted by age. To assess the relationship be-
tween hormone levels and cognitive performance, we matched each participant’s hormone
concentrations to their performance on specific cognitive tasks completed on the same day.
Partial correlations were conducted for all samples together and separately for each group
(M, W1, and W2). A p-value < 0.05 was considered statistically significant.
3. Results
3.1. Hormonal Data
Women participating in the study were characterised by a regular menstrual cycle,
with a duration in our group ranging from 25 to 35 days (Table 1). Oestradiol levels were
significantly higher in the pre-ovulatory phase than in the menstrual phase of the cycle
(
T = 5.65
;p< 0.001;
r = 0.6
), and progesterone levels were likewise higher (T = 2.48; p= 0.01;
r = 0.3
) (Figure 3). Hormonal status was as expected for the healthy women in both phases
of the menstrual cycle (Table 2). We also investigated hormone levels in men during the
study (Table 2).
Table 1. Presentation of the information on women’s menstrual cycles.
Women (n = 42)
Variable M (SD) Min Value Max Value
Length of the menstrual cycle (days) 30.05 (2.17) 25 35
Duration of the menstrual phase (days)
5.52 (0.86) 4 7
Abbreviations: n, number of participants in a given group; M, mean; SD, standard deviation; Min value, minimum
value in a given set; Max value, maximum value in a given set.
Figure 3. Changes in progesterone and oestradiol levels in women (n = 42) during two menstrual
cycle phases. Note: Data are presented as the mean
±
SE and were analysed using the Wilcoxon
signed-rank test. Significant differences are denoted by *** p< 0.001 and * p< 0.05. Progesterone is
marked in coral, while oestradiol is marked in violet.
Biology 2025,14, 1060 10 of 22
Table 2. Concentrations of hormones in groups of women and men.
Group/Phase
Testosterone
(nmol/mL)
M (SD)
Progesterone
(ng/mL)
M (SD)
Oestradiol
(pg/mL)
M (SD)
Women (n = 42)
Menstrual phase 1.32 (0.45) 0.37 (0.2) 30.86 (16.74)
Pre-ovulatory phase 1.77 (0.58) 2.06 (3.92) 163.98 (115.85)
Men (n = 29)
18.95 (6.07) 0.35 (0.19) 24.79 (8.09)
Abbreviations: n, number of participants in a given group; M, mean; SD, standard deviation.
3.2. Changes in Cognitive Performance Between Women in the Menstrual and
Pre-Ovulatory Phases
The longitudinal analysis revealed significant improvements in cognitive performance
among women during the pre-ovulatory phase compared to their performance in the
menstrual phase. Specifically, women demonstrated enhanced working memory, with
better results in the digit span forward (T = 2.06, p= 0.04, r = 0.22), digit span forward max
(T = 2.61, p= 0.01, r = 0.28), and digit span backwards max (T = 2.32, p= 0.02, r = 0.25) tests.
Performance in attention switching also improved, as indicated by a faster completion
time for the Trail Making Test B (T = 2.61, p= 0.01, r = 0.28). For all statistically significant
results, the effect size ranged from 0.2 to 0.3, indicating a small-to-medium effect size. No
significant changes were observed for other cognitive measures. Detailed results for all
within-woman comparisons are presented in Table 3.
Table 3. Changes in the cognitive performance between women in the menstrual and pre-ovulatory
phases of the cycle.
Variables Group N Mean SD Median Mean
Rank
Sum of
Ranks Tpr
Digit span
forward
W_M 42 7.33 2.54 7 Negative 133.5 2.06 0.04 * 0.22
W_PO 42 8.0 2.06 8 Positive 331.5
Digit span
forward max
W_M 42 6.24 1.38 6 Negative 93.0 2.61 0.01 * 0.28
W_PO 42 6.74 1.27 7 Positive 313.0
Digit span
backward
W_M 42 7.0 2.35 7 Negative 167.5 1.84 0.07 0.20
W_PO 42 7.48 2.08 7 Positive 360.5
Digit span
backward max
W_M 42 4.98 1.3 5 Negative 96.0 2.32 0.02 * 0.25
W_PO 42 5.43 1.21 5 Positive 282.0
TMT A time (s) W_M 42 22.83 7.41 21.45 Negative 525.5 1.55 0.12 0.17
W_PO 40 21.68 7.29 20.13 Positive 294.50
TMT B time (s) W_M 42 47.47 14.38 47.23 Negative 604.00 2.61 0.01 * 0.28
W_PO 40 41.57 9.74 41.63 Positive 216.00
TMT B/A time (s) W_M 42 2.15 0.56 2.11 Negative 489.00 1.06 0.29 0.12
W_PO 40 2.02 0.57 1.89 Positive 331.00
Corsi block span
forward
W_M 42 6.33 1.07 6 Negative 228.5 0.98 0.33 0.11
W_PO 42 6.17 1.17 6 Positive 149.5
Biology 2025,14, 1060 11 of 22
Table 3. Cont.
Variables Group N Mean SD Median Mean
Rank
Sum of
Ranks Tpr
Corsi TSF W_M 42 61.9 21.01 60 Negative 409.0 0.87 0.39 0.09
W_PO 42 58.88 21.76 54 Positive 294.0
Corsi block span
backward
W_M 42 6.60 1.29 6.00 Negative 153.00 0.27 0.79 0.03
W_PO 42 6.57 0.80 6.00 Positive 172.00
Corsi TSB W_M 42 62.10 17.23 60.00 Negative 204.50 1.81 0.07 0.20
W_PO 42 67.05 17.71 60.00 Positive 425.50
VPT max W_M 41 10.32 1.86 10 Negative 172.0 1.52 0.13 0.17
W_PO 42 10.76 1.86 11 Positive 324.0
VPT mean W_M 41 9.76 1.68 10.30 Negative 202.50 1.85 0.07 0.20
W_PO 42 10.18 1.76 10.00 Positive 427.50
VMT Vis Mem W_M 41 16.22 1.26 16.00 Negative 221.50 0.53 0.60 0.06
W_PO 40 16.38 1.41 17.00 Positive 274.50
VMT Seq Mem W_M 41 14.61 1.52 15.00 Negative 163.50 1.91 0.06 0.21
W_PO 40 15.28 1.63 15.00 Positive 364.50
Stroop A time (s) W_M 42 28.28 4.67 27.92 Negative 517.5 0.83 0.41 0.09
W_PO 42 27.85 4.1 26.45 Positive 385.5
Stroop B time (s) W_M 42 22.89 3.50 22.16 Negative 477.50 0.33 0.75 0.04
W_PO 42 22.48 2.42 22.13 Positive 425.50
Stroop C time (s) W_M 42 44.45 9.89 44.75 Negative 606.00 1.93 0.05 0.21
W_PO 42 42.21 8.03 41.53 Positive 297.00
Stroop D time (s) W_M 42 49.10 9.61 48.65 Negative 540.00 1.11 0.27 0.12
W_PO 42 47.69 9.61 47.74 Positive 363.00
Stroop
interference
W_M 42 21.56 7.8 21.44 Negative 598.0 1.83 0.07 0.20
W_PO 42 19.72 7.69 19.79 Positive 305.00
Stroop
interference a
W_M 42 16.17 7.50 13.62 Negative 596.00 1.81 0.07 0.20
W_PO 42 14.35 6.08 13.70 Positive 307.00
Stroop
interference b
W_M 42 2.06 8.37 2.65 Negative 552.50 1.26 0.21 0.14
W_PO 42 2.65 7.84 3.04 Positive 350.50
Stroop
interference c
W_M 42 4.65 7.94 4.65 Negative 429.00 0.28 0.78 0.03
W_PO 42 5.48 8.44 5.21 Positive 474.00
Note: Values marked with an asterisk (*) indicate the level of statistical significance (p< 0.05). Abbreviations: W_M,
women in the menstruation phase; W_PO, women in the pre-ovulatory phase; N, the number of participants
in a given group.; SD, standard deviation; T, the test statistic for the Wilcoxon signed-rank test; p, the p-value,
representing the probability of obtaining the observed results under the null hypothesis; p< 0.05, indicates
statistical significance, meaning there is less than a 5% probability that the observed effect occurred by chance; r,
the effect size; DSF, digit span forward; DSB, digit span backward; TMT A, Trail Making Test A; TMT B, Trail
Making Test B; TMT B/A, Trail Making Test B/A Ratio; CORSI TSF, Corsi Total Score Forward; CORSI TSB, Corsi
Total Score Backward; VPT Max, Visuospatial Test Maximum, the highest level of performance achieved in a
visuospatial test; VPT Mean, Visuospatial Test Mean, the average score in a visuospatial test, reflects overall
performance; VMT Vis Mem, Visual Memory Task—Visual Memory; VMT Seq Mem, Visual Memory Task—
Sequential Memory. Stroop interference, the difference between the times taken to complete Stroop tests C and B
(Stroop C
Stroop B); Stroop interference a, the difference between the times taken to complete Stroop tests C
and A (Stroop C
Stroop A); Stroop interference b, difference between the times taken to complete Stroop test
D and the sum of the times taken to complete Stroop tests A and B (Stroop D
(Stroop A + Stroop B); Stroop
interference c, difference between the times taken to complete Stroop tests D and C (Stroop D Stroop C).
Biology 2025,14, 1060 12 of 22
3.3. Differences in Cognitive Performance Between Men and Women in Two Phases of the
Menstrual Cycle
The cross-sectional analysis revealed significant, phase-dependent sex differences
in cognitive processing speed. An overall comparison between men (M), women in the
menstrual phase (W1), and women in the pre-ovulatory phase (W2) showed significant
group differences in the Trail Making Test A (H = 6.77, p= 0.03) and the Stroop B test
(H = 6.60, p= 0.04).
Post hoc tests specified that these differences were driven solely by the comparison
between men and women in their menstrual phase (W1), where men were significantly
faster on both the TMT A (p= 0.04) and Stroop B (p= 0.04). Crucially, as illustrated in
Figure 4, these sex differences disappeared when women were in their high-oestradiol,
pre-ovulatory phase (W2). No significant differences between the three groups were found
in any other cognitive tests. Full comparative results are shown in Table 4.
Figure 4. Changes in performance time in the TMT A and the Stroop test in task B between men and
women in two cycle phases. Note: Significant differences are denoted by * p< 0.05; Abbreviations: M,
men; W1, women in the menstruation phase; W2, women in the pre-ovulatory phase.
Table 4. Differences in cognitive performance between men and women in the two phases of the
menstrual cycle.
Cognitive Test Group Statistics
N Mean Rank Median IQR KW Statistic p
Digit span forward
W1 26 30.58 7 2
2.96 0.23
W2 16 40.22 8 4
M 29 38.53 8 4
Digit span forward max
W1 26 30.88 6 2
2.67 0.26
W2 16 39.47 6.5 2
M 29 38.67 7 2
Biology 2025,14, 1060 13 of 22
Table 4. Cont.
Cognitive Test Group Statistics
N Mean Rank Median IQR KW Statistic p
Digit span backward
W1 26 31.27 7 3
2.21 0.33
W2 16 38.25 8 3
M 29 39.00 8 4
Digit span backward max
W1 26 30.96 5 2
2.99 0.22
W2 16 36.38 5.5 2
M 29 40.31 6 3
TMT A time (s)
W1 26 43.08 22.5 11.26
6.77 0.03 *
W2 14 30.50 19.31 9.32
M 29 29.93 19.02 6.71
TMT B time (s)
W1 26 37.27 47.75 16.76
0.54 0.76
W2 14 34.07 47.91 15.19
M 29 33.41 44.55 17.78
TMT B/A time (s)
W1 26 30.88 1.89 0.56
1.97 0.37
W2 14 35.43 2.16 1.12
M 29 38.48 2.06 1.21
Corsi block span forward
W1 26 37.12 6 2
0.15 0.93
W2 16 35.97 6 3
M 29 35.02 6 2
Corsi TSF
W1 26 36.58 54 32
0.22 0.90
W2 16 37.44 57 50
M 29 34.69 54 30
Corsi block span backward
W1 26 32.79 6 1
2.27 0.32
W2 16 42.00 7 2
M 29 35.57 6 1
Corsi TSB
W1 26 29.87 57 12
4.37 0.11
W2 16 42.88 66.5 31
M 29 37.71 60 23
Biology 2025,14, 1060 14 of 22
Table 4. Cont.
Cognitive Test Group Statistics
N Mean Rank Median IQR KW Statistic p
VPT max
W1 26 34.62 11 3
1.03 0.60
W2 16 40.53 11 2
M 29 34.74 10 3
VPT mean
W1 26 34.60 10.3 3.07
0.56 0.76
W2 16 39.31 10.15 2.6
M 29 35.43 9.67 2.16
VMT Vis Mem
W1 26 33.87 16 2
0.80 0.67
W2 14 32.25 16 2
M 29 37.34 16 1
VMT Seq Mem
W1 26 33.81 14.5 3
0.40 0.82
W2 14 33.57 14.5 3
M 29 36.76 15.00 2
Stroop A time (s)
W1 26 39.69 28.88 6.8
1.35 0.51
W2 16 33.06 28.18 7.51
M 29 34.31 28.44 4.86
Stroop B time (s)
W1 26 43.37 23.58 3.47
6.60 0.04 *
W2 14 36.59 22.4 2.86
M 29 29.07 21.25 3.75
Stroop C time (s)
W1 26 37.96 45.35 13.23
0.38 0.83
W2 16 34.38 46.27 15.17
M 29 35.14 44.00 9.85
Stroop D time (s)
W1 26 36.38 52.70 13.76
0.35 0.84
W2 16 33.38 49.28 13.6
M 29 37.10 52.09 9.84
Stroop interference
W1 26 35.92 22.37 13.95
0.45 0.80
W2 16 33.28 23.09 14.45
M 29 37.57 23.68 9.99
Biology 2025,14, 1060 15 of 22
Table 4. Cont.
Cognitive Test Group Statistics
N Mean Rank Median IQR KW Statistic p
Stroop interference a
W1 26 36.50 14.11 12.8
0.17 0.92
W2 16 34.13 15.54 10.59
M 29 36.59 15.61 8.71
Stroop interference b
W1 26 32.38 2.82 15.18
2.44 0.30
W2 16 33.59 0.13 12.51
M 29 40.57 1.34 9.19
Stroop interference c
W1 26 32.08 4.30 12.68
1.49 0.47
W2 16 37.81 6.96 9.55
M 29 38.52 7.28 9.59
Note: Values marked with an asterisk (*) indicate the level of statistical significance (p< 0.05). Abbreviations:
W_1, women in the menstruation phase; W_2, women in the pre-ovulatory phase; M, men; N, the number of
participants in a given group; IQR, Interquartile Range—a measure of statistical dispersion, representing the
range between the first and third quartiles (Q1–Q3); KW Statistic, Kruskal–Wallis Test Statistic; p, the p-value,
representing the probability of obtaining the observed results under the null hypothesis; p< 0.05, indicates
statistical significance, meaning there is less than a 5% probability that the observed effect occurred by chance;
DSF, digit span forward; DSB, digit span backward; TMT A, Trail Making Test A; TMT B, Trail Making Test B;
TMT B/A, Trail Making Test B/A Ratio; CORSI TSF, Corsi Total Score Forward; CORSI TSB, Corsi Total Score
Backward; VPT Max, Visuospatial Test Maximum, the highest level of performance achieved in a visuospatial
test; VPT Mean, Visuospatial Test Mean, the average score in a visuospatial test, reflecting overall performance;
VMT Vis Mem, Visual Memory Task—Visual Memory; VMT Seq Mem, Visual Memory Task—Sequential Memory.
Stroop interference, the difference between the times taken to complete Stroop tests C and B (Stroop C
Stroop
B); Stroop interference a, the difference between the times taken to complete Stroop tests C and A (Stroop C
Stroop A); Stroop interference b, difference between the times taken to complete Stroop test D and the sum of the
times taken to complete Stroop tests A and B (Stroop D
(Stroop A + Stroop B); Stroop interference c, difference
between the times taken to complete Stroop tests D and C (Stroop D Stroop C).
3.4. Correlation Between Hormone Concentration and Cognitive Function
Within group W1 (the low-oestradiol phase), a relatively higher level of oestradiol was
related to better performance in the Stroop interference c (cor. 0.509; p= 0.009). At the same
time, an elevated oestradiol level was negatively correlated with the time score in the TMT
A test (cor. 0.513; p= 0.005) in the M group.
In group W1, the higher level of progesterone was negatively related to the results in
the digit span backwards test (cor.
0.407; p= 0.043) and Stroop interference c (cor.
0.442;
p= 0.027). Meanwhile, in the M group, progesterone levels were positively correlated with
the results in the Corsi block span forward (cor. 0.366; p= 0.055) and Corsi TSF (cor. 0.396;
p= 0.037) tests.
Testosterone levels did not correlate with any cognitive test scores. No correlations
were observed in the W2 group or when correlating all groups together.
4. Discussion
There are three main findings of the study. The first conclusion was that women’s
cognitive functioning differs according to their cycle phase. We found better short-term
memory capacity, working memory for auditory material, and attention during the high-
oestradiol phase compared to the low-oestradiol phase in a group of the same women.
In our study, we specifically investigated the predominant effect of oestradiol on
cognitive function by conducting measurements during both menstruation (low oestradiol)
Biology 2025,14, 1060 16 of 22
and the pre-ovulatory phase (high oestradiol with minimal progesterone influence). This
methodological approach differs from most of the available literature, which compares
menstrual and luteal phases [
13
,
41
45
], when both oestradiol and progesterone levels are
elevated. Such methodological differences between studies create challenges in directly
comparing research findings. Nevertheless, based on the available literature, we see
consistency between our results and data from the literature, where young women with
higher oestradiol levels showed better performance in working memory [
15
]. In the study
by Rosenberg and Park [
46
], similar to our findings, performing tasks during the high-
oestradiol phase was associated with improved verbal working memory, but there was no
noticeable effect on spatial tasks. However, the small number of participants and the fact
that the cycle phase was estimated in the Rosenberg and Park [
46
] study should be taken
into account. Contrary to our findings, previous research (comparing women in four cycle
phases) demonstrated enhanced visuospatial memory during the pre-ovulatory phase [
18
].
These discrepant results may reflect methodological differences in visuospatial assessment,
as the cited study employed location-based tasks while our battery included sequential
spatial memory (Corsi block-tapping test) and pattern recognition (visual pattern test),
suggesting that cycle effects may be task-specific within the visuospatial domain.
Our findings indicating the influence of menstrual cycle phases on cognitive functions
contrast with the study by Leeners et al. [
27
], who found no consistent associations be-
tween sex hormone levels and attention, working memory, and cognitive control in two
consecutive menstrual cycles in four cycle phases. This methodologically rigorous study
highlighted the problem of false positive results in this field, but several factors can explain
the differences in our observations. First, we used a more extended battery of cognitive
tests (in the cited study, these were the Cognitive Bias Test, Divided Attention Bimodal
Task, and Corsi—in which, as in our study, they did not observe statistically significant
changes). Second, our study focused exclusively on healthy young women. In contrast,
approximately 34% of the sample in Leeners’ study consisted of women with endocrine
disorders (endometriosis, PCOS), which may have influenced the results. Third, although
authors paid particular attention to practice effects as a potential source of false results,
we randomised the first assessment phase in our study, which may have controlled for
this confound more effectively. It is also worth noting that a later study by Leeners and
colleagues [
26
], using an ovarian stimulation model for infertility treatment, also found
no association between very high oestradiol levels and cognitive function, suggesting
that even very high levels of this hormone do not affect cognitive function directly and
unambiguously. However, it should be emphasised that the model used in the 2021 study
differs from the natural hormonal fluctuations in the menstrual cycle, where changes occur
not only in oestradiol but also in progesterone and other hormones in a strictly defined time
pattern. Nevertheless, the cited study is an important reminder of the need for cautious
interpretation of results in studies on the effects of hormones on cognitive function. It
highlights the value of replicating results across menstrual cycles—an aspect that should
be considered in future studies.
To better understand the observed changes, as well as the discrepancies between stud-
ies focusing on cognitive tests themselves, it is worth taking a closer look at neuroimaging
studies. Neuroimaging studies have demonstrated that oestradiol enhances hippocampal
activation during the pre-ovulatory phase of the menstrual cycle in both verbal and spatial
navigation tasks [9,47].
Oestradiol enhances glutamatergic neurotransmission and reduces GABAergic neuro-
transmission, creating an overall excitatory effect in the brain [
6
]. This increased neuronal
excitability may explain oestradiol’s role in boosting neural activity during cognitive tasks
in high-hormone phases of the cycle, such as the pre-ovulatory phase [
7
]. The enhance-
Biology 2025,14, 1060 17 of 22
ment of glutamatergic transmission and the reduction in GABAergic inhibition under the
influence of oestradiol increases neuronal excitability, facilitating rapid and effective data
processing necessary for maintaining concentration and manipulating information in work-
ing memory [
6
], which we observed in our study. Furthermore, oestradiol increases the
dendritic spine density in the hippocampus [
48
,
49
], which may improve memory functions,
including working memory. Studies also indicate that oestrogen affects the function of
the dopaminergic system, which plays a key role in cognitive processes such as working
memory and executive function. Higher levels of oestradiol may improve working mem-
ory performance by increasing the efficiency of information processing in the prefrontal
cortex [50].
Our second key finding showed that sex differences in information processing speed
and executive functioning between men and women were observed only when women
were in their low-oestradiol (menstrual) phase. This phase-dependent effect was partic-
ularly evident in information processing speed (TMT A time and Stroop B time). These
differences notably disappeared when women were tested during their pre-ovulatory
phase, suggesting that hormonal status plays a role in modulating cognitive sex differences.
The literature presents inconsistent results regarding sex differences in attention
[5154]
.
The reason for this lack of clarity is that many studies investigating the cognitive differences
between the sexes do not consider the hormonal changes that occur during the menstrual
cycle and their impact on the results obtained. Recent neuroimaging evidence has provided
insight into these hormone-dependent effects. Pletzer et al. [
47
] have shown that oestradiol
increases hippocampal activation during the pre-ovulatory phase, which may facilitate
information processing and cognitive performance. This is in line with our observation
of reduced sex differences in the pre-ovulatory phase, suggesting that elevated oestradiol
levels may have a compensatory function in female cognitive performance.
Furthermore, our findings complement previous research on sustained attention,
where Pletzer et al. [
45
] observed cycle-dependent variations in attention. While their
study focused on the luteal phase, showing slower response times in women compared
to men during high progesterone levels, our results extend these observations by demon-
strating that sex differences are particularly pronounced during the low-oestradiol phase.
These findings collectively suggest that both oestradiol and progesterone play distinct
roles in modulating cognitive performance, with oestradiol potentially serving a protec-
tive or enhancing function that may help eliminate baseline sex differences in cognitive
processing speed.
What is concerning is the lack of differences in the visuospatial tests in our study
between men and women. The literature suggests male predominance in visuospatial
tasks. This advantage appears to be domain-specific, primarily documented in mental
rotation [
55
,
56
] and visual motion processing tasks [
53
]. Our study’s absence of sex-related
differences in visuospatial functions may be attributed to our test selection. Our battery
included measures of visuospatial capacity and pattern retrieval (visual pattern test; VPT)
and visuospatial sequential working memory (Corsi block-tapping test) rather than tasks
involving mental rotation or motion processing. This methodological distinction may
explain why our findings diverge from the commonly reported male advantage in specific
visuospatial domains.
Our third finding has revealed complex, gender-specific associations between sex
hormone levels and cognitive functions, but only during the low oestradiol phase in women.
In men, oestradiol levels positively correlated with processing speed, while progesterone
showed associations with enhanced spatial memory capacity. However, during the low
oestradiol phase, the relationship between hormones and cognition appeared more nuanced
in women. Oestradiol demonstrated a significant negative relationship with selective
Biology 2025,14, 1060 18 of 22
attention (Stroop interference), while progesterone showed an inverse pattern, correlating
positively with selective attention but negatively with auditory working memory.
These seemingly contradictory findings can be understood through the underlying
neurobiological mechanisms. Pletzer et al. [
47
] demonstrated that oestradiol and proges-
terone exert opposing effects on neurotransmitter systems: oestradiol enhances glutamater-
gic transmission while reducing GABAergic neurotransmission, whereas progesterone
produces the opposite effect. This antagonistic relationship between these hormones at the
neurotransmitter level may explain our observed differential effects on cognitive function.
During the early follicular phase, when both hormones are at their lowest levels, the ab-
sence of oestradiol’s stimulating effect on glutamatergic transmission may contribute to
decreased performance in certain cognitive domains. Conversely, progesterone’s enhance-
ment of GABAergic inhibition could potentially impair performance through increased
neural inhibition [6].
Interestingly, our study found no significant correlations between testosterone levels
and cognitive performance in men or women. This finding may be explained by inter-
preting the results obtained in the context of the age and hormonal characteristics of our
sample. The absence of testosterone effects in our study contrasts with some previous
research showing testosterone’s influence on cognitive function, particularly in spatial
abilities and working memory [
24
]. However, studies showing testosterone’s cognitive
effects often focus on ageing populations [
23
,
57
59
]. As shown by Thilers et al. [
25
] in their
population-based study of 35–90-year-olds, associations between endogenous testosterone
levels and cognitive performance become more pronounced with age, particularly in tasks
involving processing speed and spatial abilities. This moderation according to age is partic-
ularly important because testosterone levels begin to gradually decline, by about 1–2% per
year, from the age of 30 [
60
,
61
], with the greatest decline observed in the sixth decade of
life [
24
]. Our results from a young adult sample suggest that these associations may not
be evident during the peak reproductive years when hormone levels are relatively stable.
This is consistent with other studies investigating the relationship between testosterone
levels in young adults and cognitive performance [
62
], including spatial abilities [
63
], navi-
gation and verbal fluency tasks [
64
], and working memory [
15
]. The relationship between
testosterone and cognition is complex and potentially non-linear, as demonstrated by sev-
eral foundational studies [
65
,
66
], showing that both low and high testosterone levels are
associated with poorer cognitive ability. In our study, the male participants showed testos-
terone levels within the normal age-appropriate range (laboratory norm:
8.64–29.0 nmol/l
;
results of participants: M = 18.95
±
6.07 nmol/mL); the women’s testosterone variations
were minimal (fluctuating within 0.45 nmol/mL between cycle phases). In people with
normal testosterone levels, as in our study, the effect of this hormone on cognitive function
can be challenging to observe. These findings collectively suggest that the absence of a
testosterone–cognition correlation in our study may be attributed to our sample’s age range
and the expected physiological hormone levels observed.
A limitation of our study is that our longitudinal assessment was restricted to two time
points (menstrual and pre-ovulatory phases), which limited our ability to comprehensively
assess hormonal influences throughout the menstrual cycle. To better understand the
complex relationships between oestrogen and progesterone throughout the cycle, future
studies should consider the three phases of the menstrual cycle. The second limitation
of our study was the lack of mood assessment, which prevented us from examining
how emotional state variations across the menstrual cycle might have influenced the
observed cognitive differences. Recent research suggests that menstrual cycle-related
cognitive changes are more pronounced in women with premenstrual dysphoric disorder
(PMDD), specifically regarding executive function impairments [
67
,
68
]. Nevertheless, in
Biology 2025,14, 1060 19 of 22
our study, women with dysphoric disorder were excluded from enrolment. Future research
should incorporate mood measures, as emotional states may act as moderating variables
influencing the magnitude of cognitive performance differences observed between cycle
phases and between sexes. A third limitation was the relatively small sample size, which
may have constrained the statistical power of our findings. This was primarily due to the
logistical challenges of conducting the study. Future studies with larger and more diverse
samples would enhance the robustness and generalizability of the results.
5. Conclusions
Our findings demonstrate three key aspects of hormone–cognition interactions: (1) en-
hanced cognitive performance during the pre-ovulatory phase compared to the menstrual
phase in women, only in verbal working memory and attention; (2) phase-dependent
sex differences between men and women in processing speed are present only during
women’s menstrual phase and absent during the pre-ovulatory phase; and (3) distinct
hormone–cognition relationships in men and women vary according to the menstrual cycle
phase. These results highlight the necessity of considering the phases of the menstrual
cycle in scientific and clinical research where cognitive functions are assessed, especially in
studies on sex differences.
Supplementary Materials: The following supporting information can be downloaded at: https:
//www.mdpi.com/article/10.3390/biology14081060/s1. The Supplementary Materials contain raw
data on hormone levels and cognitive test results.
Author Contributions: Conceptualisation, A.K.S. and P.J.W.; Data curation, A.K.S., K.M.M. and
B.N.; Formal analysis, A.K.S. and A.B.-G.; Funding acquisition, A.K.S.; Investigation, A.K.S., K.M.M.
and B.N.; Methodology, A.K.S. and A.B.M.; Project administration, A.K.S.; Supervision, P.J.W. and
A.B.M.; Visualisation, A.K.S., K.M.M., B.N. and A.B.-G.; Writing—original draft, A.K.S. and K.M.M.;
Writing—review and editing, M.M., P.J.W. and A.B.M. All authors have read and agreed to the
published version of the manuscript.
Funding: The research was funded by the Medical University of Gdansk—“Excellence Initiative—
Research University” Program. Additional support was provided to M.M. through the ICREA
under the ICREA Academia program. A.B.-G. received a pre-doctoral fellowship [grant number
FPU18/04344].
Institutional Review Board Statement: The study was conducted in accordance with the Declaration
of Helsinki. The study protocol was approved by the Independent Bioethics Commission for Research
at the Medical University of Gdansk (NKBBN/398/2021 and NKBBN/398-14/2023).
Informed Consent Statement: Informed consent was obtained from all individual participants
included in the study.
Data Availability Statement: The data supporting the conclusions of this article are included within
the article and its Supplementary Materials.
Acknowledgments: The authors thank all the participants involved in this study.
Conflicts of Interest: The authors declare no conflicts of interest.
References
1.
Hall, G.; Phillips, T.J. Estrogen and Skin: The Effects of Estrogen, Menopause, and Hormone Replacement Therapy on the Skin.
J. Am. Acad. Dermatol. 2005,53, 555–568. [CrossRef] [PubMed]
2.
Stricker, R.; Eberhart, R.; Chevailler, M.-C.; Quinn, F.A.; Bischof, P.; Stricker, R. Establishment of Detailed Reference Values for
Luteinizing Hormone, Follicle Stimulating Hormone, Estradiol, and Progesterone during Different Phases of the Menstrual Cycle
on the Abbott ARCHITECT®Analyzer. Clin. Chem. Lab. Med. (CCLM) 2006,44, 883–887. [CrossRef] [PubMed]
Biology 2025,14, 1060 20 of 22
3.
Brinton, R.D.; Thompson, R.F.; Foy, M.R.; Baudry, M.; Wang, J.; Finch, C.E.; Morgan, T.E.; Pike, C.J.; Mack, W.J.; Stanczyk, F.Z.;
et al. Progesterone Receptors: Form and Function in Brain. Front. Neuroendocr. Neuroendocrinol. 2008,29, 313–339. [CrossRef]
[PubMed]
4.
Wharton, W.; Gleason, C.E.; Sandra, O.; Carlsson, C.M.; Asthana, S. Neurobiological Underpinnings of the Estrogen—Mood
Relationship. Curr. Psychiatry Rev. 2012,8, 247–256. [CrossRef]
5.
Farage, M.A.; Osborn, T.W.; MacLean, A.B. Cognitive, Sensory, and Emotional Changes Associated with the Menstrual Cycle:
A Review. Arch. Gynecol. Obs. Obstet. 2008,278, 299–307. [CrossRef]
6.
Barth, C.; Villringer, A.; Sacher, J. Sex Hormones Affect Neurotransmitters and Shape the Adult Female Brain during Hormonal
Transition Periods. Front. Neurosci. 2015,9, 37. [CrossRef]
7.
Sundström Poromaa, I.; Gingnell, M. Menstrual Cycle Influence on Cognitive Function and Emotion Processingâ”from a
Reproductive Perspective. Front. Neurosci. 2014,8, 380. [CrossRef]
8.
Gegenhuber, B.; Wu, M.V.; Bronstein, R.; Tollkuhn, J. Gene Regulation by Gonadal Hormone Receptors Underlies Brain Sex
Differences. Nature 2022,606, 153–159. [CrossRef]
9.
Protopopescu, X.; Butler, T.; Pan, H.; Root, J.; Altemus, M.; Polanecsky, M.; McEwen, B.; Silbersweig, D.; Stern, E. Hippocampal
Structural Changes across the Menstrual Cycle. Hippocampus 2008,18, 985–988. [CrossRef]
10. Luine, V.N. Sex Steroids and Cognitive Function. J. Neuroendocrinol. 2008,20, 866–872. [CrossRef]
11.
Hao, J.; Rapp, P.R.; Janssen, W.G.M.; Lou, W.; Lasley, B.L.; Hof, P.R.; Morrison, J.H. Interactive Effects of Age and Estrogen on
Cognition and Pyramidal Neurons in Monkey Prefrontal Cortex. Proc. Natl. Acad. Sci. USA 2007,104, 11465–11470. [CrossRef]
12.
Keenan, P.A.; Ezzat, W.H.; Ginsburg, K.; Moore, G.J. Prefrontal Cortex as the Site of Estrogen’s Effect on Cognition. Psychoneuroen-
docrinology 2001,26, 577–590. [CrossRef]
13.
Hatta, T.; Nagaya, K. Menstrual Cycle Phase Effects on Memory and Stroop Task Performance. Arch. Sex. Behav. 2009,38, 821–827.
[CrossRef]
14.
Xu, Q.; Ji, M.; Huang, S.; Guo, W. Association between Serum Estradiol Levels and Cognitive Function in Older Women:
A Cross-Sectional Analysis. Front. Aging Neurosci. 2024,16, 1356791. [CrossRef]
15.
Hampson, E.; Morley, E.E. Estradiol Concentrations and Working Memory Performance in Women of Reproductive Age.
Psychoneuroendocrinology 2013,38, 2897–2904. [CrossRef] [PubMed]
16.
Sherwin, B.B. Estrogen and Memory in Women: How Can We Reconcile the Findings? Horm. Behav. 2005,47, 371–375. [CrossRef]
[PubMed]
17.
Šimi´c, N.; Santini, M. Verbal and Spatial Functions during Different Phases of the Menstrual Cycle. Psychiatr. Danub. 2012,24,
73–79.
18.
Solís-Ortiz, S.; Corsi-Cabrera, M. Sustained Attention Is Favored by Progesterone during Early Luteal Phase and Visuo-Spatial
Memory by Estrogens during Ovulatory Phase in Young Women. Psychoneuroendocrinology 2008,33, 989–998. [CrossRef] [PubMed]
19.
Avila-Varela, D.S.; Hidalgo-Lopez, E.; Dagnino, P.C.; Acero-Pousa, I.; del Agua, E.; Deco, G.; Pletzer, B.; Escrichs, A. Whole-Brain
Dynamics across the Menstrual Cycle: The Role of Hormonal Fluctuations and Age in Healthy Women. npj Women’s Health 2024,
2, 8. [CrossRef]
20.
Berent-Spillson, A.; Briceno, E.; Pinsky, A.; Simmen, A.; Persad, C.C.; Zubieta, J.-K.; Smith, Y.R. Distinct Cognitive Effects of
Estrogen and Progesterone in Menopausal Women. Psychoneuroendocrinology 2015,59, 25–36. [CrossRef]
21. Zitzmann, M. Testosterone and the Brain. Aging Male 2006,9, 195–199. [CrossRef]
22.
Davis, S.R.; Wahlin-Jacobsen, S. Testosterone in Women—The Clinical Significance. Lancet Diabetes Endocrinol. 2015,3, 980–992.
[CrossRef]
23.
Dratva, M.A.; Banks, S.J.; Panizzon, M.S.; Galasko, D.; Sundermann, E.E. Low Testosterone Levels Relate to Poorer Cognitive
Function in Women in an APOE-E4-Dependant Manner. Biol. Sex Differ. 2024,15, 45. [CrossRef] [PubMed]
24.
Celec, P.; Ostatníková, D.; Hodosy, J. On the Effects of Testosterone on Brain Behavioral Functions. Front. Neurosci. 2015,9, 12.
[CrossRef] [PubMed]
25.
Thilers, P.P.; MacDonald, S.W.S.; Herlitz, A. The Association between Endogenous Free Testosterone and Cognitive Performance:
A Population-Based Study in 35 to 90 Year-Oldmen and Women. Psychoneuroendocrinology 2006,31, 565–576. [CrossRef] [PubMed]
26.
Leeners, B.; Krüger, T.; Geraedts, K.; Tronci, E.; Mancini, T.; Ille, F.; Egli, M.; Röblitz, S.; Wunder, D.; Saleh, L.; et al. Cognitive
Function in Association with High Estradiol Levels Resulting from Fertility Treatment. Horm. Behav. 2021,130, 104951. [CrossRef]
27.
Leeners, B.; Kruger, T.H.C.; Geraedts, K.; Tronci, E.; Mancini, T.; Ille, F.; Egli, M.; Röblitz, S.; Saleh, L.; Spanaus, K.; et al. Lack of
Associations between Female Hormone Levels and Visuospatial Working Memory, Divided Attention and Cognitive Bias across
Two Consecutive Menstrual Cycles. Front. Behav. Neurosci. 2017,11, 120. [CrossRef]
28.
Sundström-Poromaa, I. The Menstrual Cycle Influences Emotion but Has Limited Effect on Cognitive Function. Vitam. Horm.
2018,107, 349–376. [CrossRef]
Biology 2025,14, 1060 21 of 22
29.
Munro, M.G.; Critchley, H.O.D.; Fraser, I.S. The Two FIGO Systems for Normal and Abnormal Uterine Bleeding Symptoms and
Classification of Causes of Abnormal Uterine Bleeding in the Reproductive Years: 2018 Revisions. Int. J. Gynecol. Obstet. 2018,143,
393–408. [CrossRef]
30.
Landgren, B.M.; Unden, A.L.; Diczfalusy, E. Hormonal Profile of the Cycle in 68 Normally Menstruating Women. Acta Endocrinol.
1980,94, 89–98. [CrossRef]
31.
Erdodi, L.A.; Sagar, S.; Seke, K.; Zuccato, B.G.; Schwartz, E.S.; Roth, R.M. The Stroop Test as a Measure of Performance Validity in
Adults Clinically Referred for Neuropsychological Assessment. Psychol. Assess. 2018,30, 755–766. [CrossRef] [PubMed]
32. Scarpina, F.; Tagini, S. The Stroop Color and Word Test. Front. Psychol. 2017,8, 557. [CrossRef] [PubMed]
33.
Young, J.C.; Sawyer, R.J.; Roper, B.L.; Baughman, B.C. Expansion and Re-Examination of Digit Span Effort Indices on the WAIS-IV.
Clin. Neuropsychol. 2012,26, 147–159. [CrossRef] [PubMed]
34.
Sánchez-Cubillo, I.; Periáñez, J.A.; Adrover-Roig, D.; Rodríguez-Sánchez, J.M.; Ríos-Lago, M.; Tirapu, J.; Barceló, F. Construct
Validity of the Trail Making Test: Role of Task-Switching, Working Memory, Inhibition/Interference Control, and Visuomotor
Abilities. J. Int. Neuropsychol. Soc. 2009,15, 438–450. [CrossRef]
35.
Arce, T.; McMullen, K. The Corsi Block-Tapping Test: Evaluating Methodological Practices with an Eye towards Modern Digital
Frameworks. Comput. Hum. Human. Behav. Rep. 2021,4, 100099. [CrossRef]
36.
Guariglia, C.C. Spatial Working Memory in Alzheimer’s Disease: A Study Using the Corsi Block-Tapping Test. Dement.
Neuropsychol. 2007,1, 392–395. [CrossRef]
37.
Berch, D.B.; Krikorian, R.; Huha, E.M. The Corsi Block-Tapping Task: Methodological and Theoretical Considerations. Brain Cogn.
1998,38, 317–338. [CrossRef]
38.
McInerney, V. Review of Visual Patterns Test. In The Seventeenth Mental Measurements Yearbook; Buros Institute of Mental
Measurements: Lincoln, NE, USA, 2007; pp. 842–845.
39.
Della Sala, S.; Gray, C.; Baddeley, A.; Allamano, N.; Wilson, L. Pattern Span: A Tool for Unwelding Visuo–Spatial Memory.
Neuropsychologia 1999,37, 1189–1199. [CrossRef]
40.
Colosimo, S.; Brown, T. Examining the Convergent Validity of the Test of Visual Perceptual Skills—Fourth Edition (TVPS-4) in the
Australian Context. J. Occup. Ther. Sch. Early Interv. 2022,15, 90–110. [CrossRef]
41. Hampson, E. Variations in Sex-Related Cognitive Abilities across the Menstrual Cycle. Brain Cogn. 1990,14, 26–43. [CrossRef]
42.
Phillips, S.M.; Sherwin, B.B. Variations in Memory Function and Sex Steroid Hormones across the Menstrual Cycle. Psychoneu-
roendocrinology 1992,17, 497–506. [CrossRef]
43.
Hausmann, M.; Slabbekoorn, D.; Van Goozen, S.H.M.; Cohen-Kettenis, P.T.; Güntürkün, O. Sex Hormones Affect Spatial Abilities
during the Menstrual Cycle. Behav. Neurosci. 2000,114, 1245–1250. [CrossRef]
44. Schöning, S.; Engelien, A.; Kugel, H.; Schäfer, S.; Schiffbauer, H.; Zwitserlood, P.; Pletziger, E.; Beizai, P.; Kersting, A.; Ohrmann,
P.; et al. Functional Anatomy of Visuo-Spatial Working Memory during Mental Rotation Is Influenced by Sex, Menstrual Cycle,
and Sex Steroid Hormones. Neuropsychologia 2007,45, 3203–3214. [CrossRef] [PubMed]
45.
Pletzer, B.; Harris, T.A.; Ortner, T. Sex and Menstrual Cycle Influences on Three Aspects of Attention. Physiol. Behav. 2017,179,
384–390. [CrossRef] [PubMed]
46.
Rosenberg, L.; Park, S. Verbal and Spatial Functions across the Menstrual Cycle in Healthy Young Women. Psychoneuroendocrinol-
ogy 2002,27, 835–841. [CrossRef] [PubMed]
47.
Pletzer, B.; Harris, T.A.; Scheuringer, A.; Hidalgo-Lopez, E. The Cycling Brain: Menstrual Cycle Related Fluctuations in
Hippocampal and Fronto-Striatal Activation and Connectivity during Cognitive Tasks. Neuropsychopharmacology 2019,44,
1867–1875. [CrossRef]
48.
Khan, M.M.; Dhandapani, K.M.; Zhang, Q.; Brann, D.W. Estrogen Regulation of Spine Density and Excitatory Synapses in Rat
Prefrontal and Somatosensory Cerebral Cortex. Steroids 2013,78, 614–623. [CrossRef]
49.
Yankova, M.; Hart, S.A.; Woolley, C.S. Estrogen Increases Synaptic Connectivity between Single Presynaptic Inputs and Multiple
Postsynaptic CA1 Pyramidal Cells: A Serial Electron-Microscopic Study. Proc. Natl. Acad. Sci. USA 2001,98, 3525–3530. [CrossRef]
50.
Jacobs, E.; D’Esposito, M. Estrogen Shapes Dopamine-Dependent Cognitive Processes: Implications for Women’s Health.
J. Neurosci. 2011,31, 5286–5293. [CrossRef]
51.
Feng, Q.; Zheng, Y.; Zhang, X.; Song, Y.; Luo, Y.; Li, Y.; Talhelm, T. Gender Differences in Visual Reflexive Attention Shifting:
Evidence from an ERP Study. Brain Res. 2011,1401, 59–65. [CrossRef]
52.
Evans, K.L.; Hampson, E. Sex-Dependent Effects on Tasks Assessing Reinforcement Learning and Interference Inhibition. Front.
Psychol. 2015,6, 1044. [CrossRef]
53.
Murray, S.O.; Schallmo, M.P.; Kolodny, T.; Millin, R.; Kale, A.; Thomas, P.; Rammsayer, T.H.; Troche, S.J.; Bernier, R.A.; Tadin, D.
Sex Differences in Visual Motion Processing. Curr. Biol. 2018,28, 2794–2799.e3. [CrossRef]
54.
Li, Y.; Wang, Y.; Jin, X.; Niu, D.; Zhang, L.; Jiang, S.Y.; Ruan, H.D.; Ho, G.W. Sex Differences in Hemispheric Lateralization of
Attentional Networks. Psychol. Res. 2021,85, 2697–2709. [CrossRef]
Biology 2025,14, 1060 22 of 22
55.
Voyer, D. Time Limits and Gender Differences on Paper-and-Pencil Tests of Mental Rotation: A Meta-Analysis. Psychon. Bull. Rev.
2011,18, 267–277. [CrossRef]
56.
Voyer, D.; Voyer, S.D.; Saint-Aubin, J. Sex Differences in Visual-Spatial Working Memory: A Meta-Analysis. Psychon. Bull. Rev.
2017,24, 307–334. [CrossRef] [PubMed]
57.
Holland, J.; Bandelow, S.; Hogervorst, E. Testosterone Levels and Cognition in Elderly Men: A Review. Maturitas 2011,69, 322–337.
[CrossRef] [PubMed]
58.
Dong, X.; Jiang, H.; Li, S.; Zhang, D. Low Serum Testosterone Concentrations Are Associated With Poor Cognitive Performance
in Older Men but Not Women. Front. Aging Neurosci. 2021,13, 712237. [CrossRef] [PubMed]
59.
Giannos, P.; Prokopidis, K.; Church, D.D.; Kirk, B.; Morgan, P.T.; Lochlainn, M.N.; Macpherson, H.; Woods, D.R.; Ispoglou, T.
Associations of Bioavailable Serum Testosterone With Cognitive Function in Older Men: Results From the National Health and
Nutrition Examination Survey. J. Gerontol.-Ser. A Biol. Sci. Med. Sci. 2023,78, 151–157. [CrossRef]
60.
Kaufman, J.M.; Vermeulen, A. The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications.
Endocr. Rev. 2005,26, 833–876. [CrossRef]
61.
Harman, S.M.; Metter, E.J.; Tobin, J.D.; Pearson, J.; Blackman, M.R. Longitudinal Effects of Aging on Serum Total and Free
Testosterone Levels in Healthy Men. J. Clin. Endocrinol. Metab. 2001,86, 724–731. [CrossRef]
62.
Halari, R.; Hines, M.; Kumari, V.; Mehrotra, R.; Wheeler, M.; Ng, V.; Sharma, T. Sex Differences and Individual Differences in
Cognitive Performance and Their Relationship to Endogenous Gonadal Hormones and Gonadotropins. Behav. Neurosci. 2005,
119, 104–117. [CrossRef]
63.
Puts, D.A.; Cárdenas, R.A.; Bailey, D.H.; Burriss, R.P.; Jordan, C.L.; Breedlove, S.M. Salivary Testosterone Does Not Predict Mental
Rotation Performance in Men or Women. Horm. Behav. 2010,58, 282–289. [CrossRef]
64.
Scheuringer, A.; Pletzer, B. Sex Differences and Menstrual Cycle Dependent Changes in Cognitive Strategies during Spatial
Navigation and Verbal Fluency. Front. Psychol. 2017,8, 381. [CrossRef]
65.
Gouchie, C.; Kimura, D. The Relationship between Testosterone Levels and Cognitive Ability Patterns. Psychoneuroendocrinology
1991,16, 323–334. [CrossRef]
66.
Moffat, S.; Hampson, E. A Curvilinear Relationship between Testosterone and Spatial Cognition in Humans: Possible Influence of
Hand Preference. Psychoneuroendocrinology 1996,21, 323–337. [CrossRef]
67.
Le, J.; Thomas, N.; Gurvich, C. Cognition, the Menstrual Cycle, and Premenstrual Disorders: A Review. Brain Sci 2020,10, 198.
[CrossRef]
68.
Yen, J.Y.; Lin, P.C.; Hsu, C.J.; Lin, C.; Chen, I.J.; Ko, C.H. Attention, Response Inhibition, Impulsivity, and Decision-Making
within Luteal Phase in Women with Premenstrual Dysphoric Disorder. Arch. Womens Ment. Health 2023,26, 321–330. [CrossRef]
[PubMed]
Disclaimer/Publishers Note: The statements, opinions and data contained in all publications are solely those of the individual
author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to
people or property resulting from any ideas, methods, instructions or products referred to in the content.